Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
British Journal of Haematology
|
January 31, 2024
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations
Gayathri Ravi, Susan Bal, Laura Joiner, et al.
Bone Marrow Transplantation
|
January 9, 2021
Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantation
Omer Jamy, Alice Chen, Kevin Battles, et al.
Journal of Geriatric Oncology
|
July 30, 2022
Disparities in clinical trial participation among older adults with multiple myeloma in the United States
Priscila White, Abigail Cooley, Susan Bal, et al.
Blood
|
April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
Smith Giri, Binod Dhakal, Natalie S Callander, et al.
Transplantation and Cellular Therapy
|
June 14, 2024
Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant
Kyle Kidwell, Susan Bal, Kelly Godby, et al.
American Journal of Hematology
|
January 19, 2022
Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma
Smith Giri, Susan Bal, Kelly N Godby, et al.
Blood Cancer Journal
|
February 5, 2025
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Luciano J Costa, Eva Medvedova, Binod Dhakal, et al.
JAMA Oncology
|
September 24, 2020
Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis
Smith Giri, Alyssa Grimshaw, Susan Bal, et al.
Blood Cancer Journal
|
April 23, 2025
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Journal of Geriatric Oncology
|
May 7, 2024
Understanding health outcome preferences of older adults diagnosed with multiple myeloma
Supriya Maheshwari, Miguel Arias, Clare Ubersax, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
British Journal of Haematology
|
January 31, 2024
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations
Gayathri Ravi, Susan Bal, Laura Joiner, et al.
Bone Marrow Transplantation
|
January 9, 2021
Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantation
Omer Jamy, Alice Chen, Kevin Battles, et al.
Journal of Geriatric Oncology
|
July 30, 2022
Disparities in clinical trial participation among older adults with multiple myeloma in the United States
Priscila White, Abigail Cooley, Susan Bal, et al.
Blood
|
April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
Smith Giri, Binod Dhakal, Natalie S Callander, et al.
Transplantation and Cellular Therapy
|
June 14, 2024
Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant
Kyle Kidwell, Susan Bal, Kelly Godby, et al.
American Journal of Hematology
|
January 19, 2022
Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma
Smith Giri, Susan Bal, Kelly N Godby, et al.
Blood Cancer Journal
|
February 5, 2025
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Luciano J Costa, Eva Medvedova, Binod Dhakal, et al.
JAMA Oncology
|
September 24, 2020
Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis
Smith Giri, Alyssa Grimshaw, Susan Bal, et al.
Blood Cancer Journal
|
April 23, 2025
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Journal of Geriatric Oncology
|
May 7, 2024
Understanding health outcome preferences of older adults diagnosed with multiple myeloma
Supriya Maheshwari, Miguel Arias, Clare Ubersax, et al.
Page
of 7